Comment on: EGFR mutational status in Brazilian patients with penile carcinoma

Abstract

The authors describe the results on EGFR molecular alterations of 29 Brazilian patients with penile carcinoma (PC). DNA extracted from frozen tumor tissue of all patients was submitted to direct sequencing of the four exons (18 – 21) responsible for the EGFR tyrosine-kinase activity. Corroborating the data by Di Lorenzo et al. published in Expert Opin Ther Targets, none of the sequenced tumor samples showed relevant alterations in the four studied exons of the EGFR gene.

Keywords::

• EGFR mutations
• molecular diagnostics
• penile carcinoma
• target therapy
• tyrosine-kinase inhibitors